Effect of Concurrent Chemoradiation Therapy on Respiratory Muscle Performance, Lung Function and Functional Capacity in Patients With Local Esophagus Cancer
NCT03120572 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 45
Last updated 2017-04-19
Summary
The purpose of this study is to investigate the effect of concurrent chemoradiation therapy on respiratory muscle performance, lung function and functional capacity in patients with local esophagus cancer.
Conditions
- Esophageal Cancer
Sponsors & Collaborators
-
Mackay Memorial Hospital
lead OTHER
Eligibility
- Min Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-08-31
- Primary Completion
- 2016-02-29
- Completion
- 2016-02-29
Countries
- Taiwan
Study Locations
More Related Trials
-
AK104 Plus Concurrent Chemoradiation Therapy in Esophageal Squamous Cell Carcinoma
NCT05594914 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
CCRT With Twice Weekly Paclitaxel and Cisplatin Followed by Surgery for Locally Advanced Esophageal Cancer
NCT00154804 ·Status: COMPLETED ·Phase: PHASE2
-
Phase III Study of Neo-adjuvant Chemoradiotherapy Followed by Surgery for Squamous Cell Esophageal Cancer
NCT01216527 ·Status: UNKNOWN ·Phase: PHASE3
-
Study of Simultaneous Modulated Accelerated Radiation Therapy Concurrent With Chemotherapy to Treat Esophageal Cancer
NCT01670409 ·Status: COMPLETED ·Phase: PHASE2
-
Prospective Phase II Clinical Study of Neoadjuvant Chemoradiotherapy Combined With PD-1/PD-L1 Inhibitors in the Treatment of Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
NCT06888531 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Retrospective Clinical Study Exploring Prognostic Factors in Esophageal Cancer Patients
NCT06960889 ·Status: ACTIVE_NOT_RECRUITING
-
Concurrent Chemoradiotherapy After Endoscopic Resection for Stage I Esophageal Carcinoma
NCT04275986 ·Status: UNKNOWN ·Phase: PHASE2
-
Fraction Dose Escalation of Split-course Hypofractionated Concurrent Chemoradiotherapy Following Induction Chemo-immunotherapy in Unresectable Locally Advanced Esophageal Squamous Carcinoma: a Phase I Study.
NCT06020885 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Hypofractionated vs. Conventional Chemoradiotherapy After Induction Chemo-immunotherapy for Unresectable Esophageal Squamous Cell Carcinoma
NCT06912074 ·Status: RECRUITING ·Phase: PHASE2
-
The Application of 3T MRI in Esophageal Cancer
NCT03635619 ·Status: UNKNOWN
-
Concurrent Radiotherapy Following Induction Chemoimmunotherapy for Locally Advanced Esophageal Cancer
NCT07015489 ·Status: COMPLETED ·Phase: PHASE2
-
Neoadjuvant Immunotherapy Combined With Chemotherapy in Patients With Locally Advanced ESCC
NCT05807542 ·Status: COMPLETED ·Phase: PHASE2
-
Chemoradiation Versus Esophagectomy for Locally Advanced Esophageal Cancer
NCT02972372 ·Status: RECRUITING ·Phase: NA
-
Comparison of Chemoradiotherapy and Chemoradiotherapy Combined With Consolidation Chemotherapy for ESCC
NCT05775419 ·Status: RECRUITING ·Phase: NA
-
Study of Concurrent Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma
NCT02964455 ·Status: COMPLETED ·Phase: PHASE1
-
Trial of Concurrent Chemoradiotherapy for Locally Advanced Esophageal Cancer
NCT02762474 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Adjuvant Chemotherapy in Combination With Tislelizumab in Lymph Node-Positive Esophageal Squamous Cell Carcinoma
NCT05984342 ·Status: RECRUITING ·Phase: PHASE1
-
Comparison Between NCRT and NCT Followed by MIE for Treatment of Locally Advanced Resectable ESCC
NCT03001596 ·Status: COMPLETED ·Phase: NA
-
Neoadjuvant Chemoradiotherapy Combined With Perioperative Toripalimab in Locally Advanced Esophageal Cancer
NCT04437212 ·Status: UNKNOWN ·Phase: PHASE2
-
High-dose Intensity Modulated Radiotherapy and Concurrent Chemotherapy in Esophageal Cancer
NCT03535207 ·Status: UNKNOWN ·Phase: NA
-
Postoperative Concurrent Chemoradiotherapy Versus Radiotherapy Alone for Patients With Locoregionally Advanced Esophageal Squamous Cell Carcinoma
NCT03600831 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study on Adjuvant Chemotherapy After Total Two-field Lymph Node Dissection of Thoracic Esophageal Squamous Cell Carcinoma
NCT04174079 ·Status: RECRUITING ·Phase: NA
-
Concurrent Radiotherapy and Weekly Chemotherapy of PF for Postoperative Locoregional Recurrence of Esophageal Cancer
NCT02325986 ·Status: UNKNOWN ·Phase: PHASE2
-
Evaluation of Neoadjuvant Therapy Efficacy and Postoperative Pathological Indicators in Esophageal Cancer Using CT and Multimodal MRI
NCT06833775 ·Status: NOT_YET_RECRUITING
-
The Impact of Two-field or Three-field Lymphadenectomy on Overall Survival in Middle and Lower Thoracic Esophageal Squamous Cell Carcinoma: An Observational Study
NCT05617352 ·Status: COMPLETED